Hypertension is very common in adults≥ 60 years of age. Isolated systolic hypertension
(ISH) in particular is a good predictor of events associated with elevated blood pressure …

Abstract The Systolic Hypertension in the Elderly Program (SHEP) Pilot Study was
conducted to determine the feasibility of conducting a long-term placebo-controlled …

A postal survey of 445 medical practitioners was carried out in the light of recent large
studies supporting the treatment of isolated systolic hypertension (ISH) in the elderly. The …

Syst-Eur is a multicenter placebo-controlled outcome trial designed by the European
Working Pany on High Blood Pressure in the Elderly to investigate the effect of …

Introduction Systolic hypertension is very common in the elderly and is strongly associated
with the risk of cardiovascular and cerebrovascular events. The control of systolic …

Systolic hypertension is difficult to control in the elderly, but this is not an excuse for denying
these patients the benefits of carefully controlled antihypertensive treatment, particularly …

Now that the benefits of treating diastolic hypertension in the elderly have been convincingly
proved, attention is turning to the need for, and the choice of, treatment of isolated systolic …

In a large, open, multicenter study, 2,206 outpatients with mild-to-moderate essential
hypertension were recruited by 755 cardiologists throughout France. Patients received …

This paper summarizes the evidence supporting the pharmacological treatment of
hypertension in the elderly as well as some the remaining controversies. The world is …

During normal aging, systolic blood pressure (SBP) rises and a large proportion of elderly
people develop isolated systolic hypertension (ISH). ISH was previously considered to be a …